Eris Lifesciences acquires entire stake of UTH Healthcare: Report

05 Oct 2017 Evaluate

Eris Lifesciences has reportedly acquired the entire stake of the Pune-based UTH Healthcare for a consideration of Rs 12.85 crore in an all-cash deal. The deal was completed on October 1.

Set up in 2011, UTH Healthcare has operations in the pharmaceuticals and neutraceuticals industry with annual turnover of Rs 25.57 as on March 31, 2017.

Eris Lifesciences is engaged in manufacturing, marketing and selling of branded generics within the chronic and acute categories of the Indian Pharmaceutical Market.

Eris Lifesciences Share Price

1552.75 -5.65 (-0.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×